Loading insider details...
Beta
Latest Form 4 (Sep 21, 2026): Grant/Award of 25,666 ADIL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Grant/Award | 25,666 | n/a |
| Jun 16, 2026 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Purchase | 36,378 | $100.0K |
| Jun 10, 2026 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 15,200 | n/a |
| Sep 11, 2025 | Rapport Therapeutics, Inc. (RAPP) | Purchase | 3,500 | $79.1K |
| Jun 18, 2025 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 10,925 | n/a |
| Mar 13, 2025 | Rapport Therapeutics, Inc. (RAPP) | Purchase | 6,000 | $61.2K |
| Nov 8, 2024 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 29,756 | n/a |